{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T04:44:15Z","timestamp":1762577055744,"version":"build-2065373602"},"reference-count":15,"publisher":"Japan Surgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Case Rep"],"published-print":{"date-parts":[[2025]]},"DOI":"10.70352\/scrj.cr.25-0279","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T22:10:18Z","timestamp":1762467018000},"page":"n\/a","source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Survival Achieved with Multimodal Therapy and Multiple Hepatic Resections for Pancreatic Primary Mixed Neuroendocrine\u2013Non-Neuroendocrine Neoplasm Comprising Acinar Cell Carcinoma and Neuroendocrine Carcinoma: A Case Report"],"prefix":"10.70352","volume":"11","author":[{"given":"Hiroto","family":"Arino","sequence":"first","affiliation":[{"name":"Department of Surgery, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuki","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoe","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Koyama","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Okamura","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Saji","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobu","family":"Oshima","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Narita","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Uryuhara","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kaihara","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"51119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Nagtegaal ID, Odze RD, Klimstra D, et al. WHO Classification of Tumours Editorial Board. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020; 76: 182\u2013188.","DOI":"10.1111\/his.13975"},{"key":"2","unstructured":"2) Klimstra DS, Hruban RH, Kl\u00f6ppel G, et al. Acinar cell neoplasms of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO Classification of Tumours of the Digestive System. 4th ed. Lyon: IARC: 2010; 314\u2013318."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Klimstra DS, Adsay V. Acinar neoplasms of the pancreas\u2014a summary of 25 years of research. Semin Diagn Pathol 2016; 33: 307\u201318.","DOI":"10.1053\/j.semdp.2016.05.009"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Yao JC, Hassan M, Phan A, et al. One hundred years after \u201cCarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008; 26: 3063\u201372.","DOI":"10.1200\/JCO.2007.15.4377"},{"key":"5","unstructured":"5) The Japan NeuroEndocrine Tumor Society (JNETS). Clinical Practice Guidelines for Gastroenteropancreatic Neuroendocrine Neoplasm (GEP-NEN) 2019. https:\/\/jnets.umin.jp\/pdf\/guideline002_2s.pdf (in Japanese) Accessed 21 Aug. 2025."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Pavel M, \u00d6berg K, Falconi M, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2020; 31: 844\u201360.","DOI":"10.1016\/j.annonc.2020.03.304"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Shah MH, Goldner WS, Benson AB, et al. Neuroendocrine and adrenal tumors, version 2.2021, NCCN Clinical Practice Guidelines in oncology. J Natl Compr Canc Netw 2021; 19: 839\u2013868.","DOI":"10.6004\/jnccn.2021.0032"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Chin K, Baba S, Hosaka H, et al. Irinotecan plus cisplatin for therapy of small-cell carcinoma of the esophagus: report of 12 cases from single institution experience. Jpn J Clin Oncol 2008; 38: 426\u201331.","DOI":"10.1093\/jjco\/hyn041"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Okita NT, Kato K, Takahari D, et al. Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma. Gastric Cancer 2011; 14: 161\u20135.","DOI":"10.1007\/s10120-011-0025-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kulke MH, Wu B, Ryan DP, et al. A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors. Dig Dis Sci 2006; 51: 1033\u20138.","DOI":"10.1007\/s10620-006-8001-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Jin S, Wang T, Chen X, et al. Phase II study of weekly irinotecan plus cisplatin in patients with previously untreated extensive-stage extrapulmonary small cell carcinoma. Onkologie 2011; 34: 378\u201381.","DOI":"10.1159\/000329609"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Morizane C, Machida M, Honma Y, et al. Effectiveness of Etoposide and Cisplatin vs Irinotecan and cisplatin therapy for patients with advanced Neuroendocrine Carcinoma of the Digestive System: the TOPIC-NEC Phase 3 Randomized Clinical Trial. JAMA Oncol 2022; 8: 1447\u201355.","DOI":"10.1001\/jamaoncol.2022.3395"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Frizziero M, Chakrabarty B, Nagy B, et al. Mixed neuroendocrine non-neuroendocrine neoplasms: a systematic review of a controversial and underestimated diagnosis. J Clin Med 2020; 9: 273.","DOI":"10.3390\/jcm9010273"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Egal A, Cros J, Svrcek M, et al. Prognostic factors of acinar cell carcinomas: a study of 44 patients. Pancreas 2019; 48: 1393\u20136.","DOI":"10.1097\/MPA.0000000000001440"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Strait AM, Sharma N, Tsapakos MJ, et al. Pancreatic mixed acinar-neuroendocrine carcinoma, a unique diagnostic challenge on FNA cytology: a small series of two cases with literature review. Diagn Cytopathol 2018; 46: 971\u20136.","DOI":"10.1002\/dc.23981"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/11\/1\/11_cr.25-0279\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T04:42:07Z","timestamp":1762576927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/11\/1\/11_cr.25-0279\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.70352\/scrj.cr.25-0279","relation":{},"ISSN":["2198-7793"],"issn-type":[{"type":"electronic","value":"2198-7793"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"cr.25-0279"}}